Home | Publications | Diseases | Pain place holder
place holder place holder

Pain

Survey of Private Companies Active in Pain Drug R&D; A


Publication Date   January 2006
Publisher   Startupguys
Product Type   Directory
Pages   128
ISBN Number   not applicable
Product Code   SUP002
Ask a question about this product?

Price £415.00

approximately: $775 | €526

Summary


This spin-off report of "A Survey of Private Companies Active in CNS & PNS Drug R&D" comprises the private companies active in pain R&D covered in the full report. Launched in March 2006 the product combines an Excel company database covering 72 companies active in pain drug research and development with a full cross-referenced report in PDF format describing each company in detail. Contact details, descriptive background information, management team, investors and CNS/PNS drug pipeline are provided for all entries. "A Survey of Private Companies Active in Pain Drug R&D" is by far the most comprehensive survey of private players active in the pain market space available to this date. It is a must have report for everyone professionally involved in pain drug development and pain drug development companies.

View sample in PDF format

Content


Companies Surveyed:-
ActivBiotics
Addex Pharmaceuticals
Aegera Therapeutics
Algos Therapeutics
Apeiron Biologics
Arakis (Sosei Subsidiary)
ARGOLYN Bioscience
Asilomar Pharmaceuticals
Biovex
Boehringer-Ingelheim
Britannia Pharmaceutical (Forum Bioscience Subsidiary)
Cambridge Biotechnology (Biovitrum Subsidiary)
Cannasat Therapeutics
Cara Therapeutics
Cerimon Pharmaceuticals
Chiesi Group / Chiesi Farmaceutici S.p.A.
Cognetix
conoGenetix Bioscience
Dexcel
Elbion
Esteve
Grnenthal
Howard Associates
i3 Research
Ingenium Pharmaceuticals
Janssen Pharmaceutica (J&J subsidiary)
Jazz Pharmaceuticals
Juvantia Pharma
Kadmus Pharmaceuticals
KAI Pharmaceuticals
Marinus Pharmaceuticals
MedPointe
Molecular Synthetics
Neuraxon
Neurobiomed
NeuroDetective
NeuroDigm
Neurofit
NeurogesX
Neuroinvestigations
Neurology Clinical Research
NeuroMed Technologies
Neuromolecular Pharmaceuticals
Neurosolutions (Neurodiscovery subsidiary)
Neurotargets
Newron Pharmaceuticals
NiKem Research
Novasite Pharmaceuticals
NsGene (Neurosearch Spin-off)
Nura
Nyxis Neurotherapies
PainCeptor Pharma Corporation
Paradigm Therapeutics
Predix Pharmaceuticals
PsychoGenics
Psyncro
Purdue Pharma (Mundipharma/Napp)
Rinat Neuroscience
Rivanna Pharmaceuticals
Scion Pharmaceuticals
Solstice Neurosciences
Targacept
TorreyPines Therapeutics
Trophos
Vela Pharmaceuticals
Ventana CRC
Vistagen Therapeutics
Xenome
Xenon Pharmaceuticals
Xention Discovery
Xsira Pharmaceuticals
Yaupon Therapeutics